首页 > 市场调查报告书 > 医疗设备

心血管设备

心臟再同步治疗（CRT）市场规模、份额和成长分析（按产品、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1896754

心臟再同步治疗（CRT）市场规模、份额和成长分析（按产品、应用、最终用户和地区划分）－2026-2033年产业预测

Cardiac Resynchronization Therapy Market Size, Share, and Growth Analysis, By Product, By Application (Intraventricular Desynchrony, Interventricular Desynchrony), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，心臟再同步治疗市场规模将达到 44.6 亿美元，到 2025 年将达到 46.8 亿美元，到 2033 年将达到 68.1 亿美元，预测期（2026-2033 年）的复合年增长率为 4.8%。

心臟再同步治疗市场分析显示，心臟病和心臟病发作发生率的上升，以及医疗保健投资和支出的增加，是成长要素。技术进步和医疗设备的现代化将进一步促进市场扩张，尤其是在新兴市场和老龄化社会。然而，不利的医疗改革、手术部位感染风险的增加以及器械的高敏感性等挑战依然存在，这些挑战可能会阻碍市场发展。相关人员在应对不断变化的心臟再同步治疗市场格局时，必须认真考虑这些因素，权衡机会与潜在限制，以优化患者疗效并推动市场创新。

心臟再同步治疗市场驱动因素

心臟病及其相关危险因子的盛行率持续上升，显着推高了对心臟再同步治疗设备的需求。儘管预防和治疗策略不断取得进展，但猝死仍然是主要死因之一。心臟衰竭始终名列全球主要死因之列，凸显了有效治疗方法的迫切性。随着心血管疾病患者数量的增加，心臟再同步治疗市场预计将会扩大，因为改善患者预后和应对心臟疾病管理的重大挑战至关重要。

心臟再同步治疗市场的限制

由于产品召回，心臟再同步治疗市场正面临严峻挑战，引发人们对某些设备可靠性的担忧。主要製造商在发现可能影响设备性能的潜在安全问题后，被迫召回包括某些起搏器和CRT-P在内的多种型号产品。这影响到先前已分销的数千台设备，凸显了技术故障带来的风险。此类召回可能削弱消费者信心和病人安全，最终阻碍市场成长，并导致监管审查力度加大。这可能导致该领域新设备的监管更加严格，核准流程也更加漫长。

心臟再同步治疗（CRT）市场趋势

由于心臟衰竭盛行率不断上升以及由此带来的猝死风险增加，心臟再同步治疗（CRT）市场正经历显着成长。 CRT-D（去心房颤动）结合了传统起搏器的功能和纠正危及生命的心律不整的能力，因其更优的治疗效果而日益普及。智慧型手机连接、远端监测和人性化设计等创新功能吸引了希望积极参与自身治疗的患者。此外，电池续航力长和磁振造影相容性等特性也提升了CRT-D设备的吸引力，使其成为在不断发展的循环系统医疗环境中管理心臟衰竭和改善患者预后的重要工具。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Medtronic plc（Ireland）
Boston Scientific Corporation（USA）
Abbott Laboratories（USA）
BIOTRONIK SE & Co. KG（Germany）
Lepu Medical Technology Co., Ltd.（China）
MicroPort Scientific Corporation（China）
LivaNova PLC（UK）
Medico SpA（Italy）
Nihon Kohden Corporation（Japan）
Koninklijke Philips NV（Netherlands）
Japan Lifeline Co., Ltd.（Japan）
Shree Pacetronix Ltd.（India）
Integer Holdings Corporation（OSCOR Inc.）（USA）
Osypka Medical GmbH（Germany）
St. Jude Medical, Inc.（acquired by Abbott）（USA）
Accellent Inc.（USA）
Cameron Health（acquired by Emerson Electric Co.）（USA）
Sorin Group（acquired by LivaNova）（Italy）
Guidant Corporation（acquired by Boston Scientific）（USA）
Cyberonics, Inc.（acquired by Abbott）（USA）

结论与建议

简介目录

Product Code: SQMIG35D2074

Cardiac Resynchronization Therapy Market size was valued at USD 4.46 Billion in 2024 and is poised to grow from USD 4.68 Billion in 2025 to USD 6.81 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).

Market insights into Cardiac Resynchronization Therapy indicate a significant growth trajectory influenced by rising incidence of heart disease and heart attacks, alongside increased healthcare investment and spending. Advancements in technology and the modernization of medical equipment further contribute to market expansion, particularly in emerging markets and among an aging population. However, challenges exist, including unfavorable healthcare reforms, the heightened risk of surgical site infections, and the high sensitivity of devices, which may impede market progress. These factors will require careful consideration as stakeholders navigate the evolving landscape of cardiac resynchronization therapy, balancing opportunities with potential constraints in order to optimize patient outcomes and drive market innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiac Resynchronization Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiac Resynchronization Therapy Market Segments Analysis

Global Cardiac Resynchronization Therapy Market is segmented by product, application, end user and region. Based on product, the market is segmented into cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers. Based on application, the market is segmented into intraventricular desynchrony, interventricular (V-V) desynchrony and atrioventricular (A-V) desynchrony. Based on end user, the market is segmented into hospitals & cardiac centers, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cardiac Resynchronization Therapy Market

The prevalence of heart diseases and related risk factors continues to rise, contributing significantly to the demand for cardiac resynchronization therapy devices. Sudden cardiac death remains a leading cause of mortality, even with ongoing advancements in prevention and treatment strategies. Heart failure consistently ranks among the top causes of death globally, highlighting the urgent need for effective therapies. As more individuals are affected by cardiovascular conditions, the market for cardiac resynchronization therapy is expected to expand, driven by the necessity to improve patient outcomes and address the critical challenges associated with managing heart-related disorders.

Restraints in the Cardiac Resynchronization Therapy Market

The Cardiac Resynchronization Therapy market is facing significant challenges due to product recalls, which have raised concerns about the reliability of certain devices. Notable manufacturers have had to withdraw various models, including specific pacemakers and CRT-Ps, after discovering potential safety issues that could compromise device performance. This has impacted thousands of devices that were previously distributed, highlighting the risks associated with technological malfunctions. Such recalls can undermine consumer confidence and patient safety, ultimately hindering market growth and increasing scrutiny from regulatory bodies, which may result in tighter regulations and longer approval processes for new devices in the sector.

Market Trends of the Cardiac Resynchronization Therapy Market

The Cardiac Resynchronization Therapy (CRT) market is experiencing significant growth driven by the increasing prevalence of heart failure and associated risks of sudden cardiac death. CRT-Defibrillators (CRT-D), which combine the functionalities of traditional pacemakers with the ability to correct life-threatening arrhythmias, are gaining popularity due to their enhanced therapeutic capabilities. Innovations such as smartphone connectivity, remote monitoring, and user-friendly designs are appealing to patients seeking greater engagement in their treatment. Additionally, features like extended battery life and MRI compatibility bolster the appeal of CRT-D devices, positioning them as essential tools in managing heart failure and improving patient outcomes in an evolving cardiovascular landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Cardiac Resynchronization Therapy Market Size by Product & CAGR (2026-2033)

Market Overview
Cardiac Resynchronization Therapy Defibrillators
Cardiac Resynchronization Therapy Pacemakers

Global Cardiac Resynchronization Therapy Market Size by Application & CAGR (2026-2033)

Market Overview
Intraventricular Desynchrony
Interventricular (V-V) Desynchrony
Atrioventricular (A-V) Desynchrony

Global Cardiac Resynchronization Therapy Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Cardiac Centers
Ambulatory Surgery Centers
Others

Global Cardiac Resynchronization Therapy Market Size & CAGR (2026-2033)

North America (Product, Application, End User)
- US
- Canada
Europe (Product, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medico S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Japan Lifeline Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shree Pacetronix Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integer Holdings Corporation (OSCOR Inc.) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka Medical GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
St. Jude Medical, Inc. (acquired by Abbott) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accellent Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cameron Health (acquired by Emerson Electric Co.) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sorin Group (acquired by LivaNova) (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guidant Corporation (acquired by Boston Scientific) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyberonics, Inc. (acquired by Abbott) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments